Flaviu’s research is in the area of Cancer Imaging, with a specific focus on early detection of treatment response. Current interests and projects include: novel fluorine-18 radiochemistry; PET imaging of cell death as a method of early treatment response in cancer; Imaging sialylation of glycans with applications in monitoring treatment response in cancer. He is currently transferring the C2Am protein labelling process from a pre-clinical setting to a GMP compliant one.